<DOC>
	<DOCNO>NCT03028298</DOCNO>
	<brief_summary>Each year , approximately 30,000 people United States suffer intra-cranial hemorrhage due aneurysmal rupture . Of survive initial event , 40 % go neurological injury secondary stroke ( delayed cerebral ischemia ) cause constriction blood vessel ( i.e . vasospasm ) . Previous study show medication sildenafil , give intravenously , improve vasospasm , associate degree hypotension . The degree hypotension well within safety threshold patient . Sildenafil medication strongly inhibit protein phosphodiesterase-V ( PDE-V ) . The hypothesis study oral sildenafil also improve vasospasm , result much hypotension . Specifically , investigator look show comparable dos oral sildenafil produce degree PDE-V inhibition intravenous dose degree hypotension reduce . Additionally , use measurement cerebral blood flow regulation acquire use transcranial Doppler ultrasound , investigator look show oral sildenafil produce degree improvement vasospasm blood flow regulation .</brief_summary>
	<brief_title>Sildenafil DCI</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>1 . Age &gt; = 21 2 . Onset symptom within 72 hour presentation 3 . Subarachnoid hemorrhage rupture cerebral aneurysm 4 . Cerebral vasospasm diagnose transcranial doppler , CT angiography , digital subtraction angiography 1 . Pregnancy 2 . Subarachnoid hemorrhage secondary traumatic mycotic aneurysm 3 . Preictal sildenafil therapy ( last dose within 1 week presentation ) 4 . Contraindications sildenafil therapy ( i.e . use nitrate , leave ventricular outflow obstruction , impaired autonomic blood pressure control )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>